Insulet: Barclays initiates coverage with equal-weight rating and $150 target price
PODD•Barclays initiated coverage of Insulet with an equal-weight rating and a $150 target price.
Related News
Vaxcyte edges lower after $1 billion raise to fund pneumococcal vaccine
PCVX•
Lantronix CEO Awsare to meet investors, defense customers at AUSA 2026 conference
LTRX•
Zscaler, Inc.: Rosenblatt Securities raises target price to $250 from $200
ZS•
ServiceNow: Argus Research raises target price to $170 from $134
NOW•
BMO cuts J.B. Hunt Transport Services target price to $315 from $320
JBHT•